Table 2. Safety data of biosimilar Pegaspargase (Asviia).
Adverse Events | Number (n=45) | (%) |
Sepsis/febrile neutropenia | 8 | 17.8 |
Allergy | 6 | 13.3 |
Vomiting | 6 | 13.3 |
Hyperglycemia | 5 | 11.1 |
Transaminitis event | 2 | 4.44 |
Pancreatitis | 2 | 4.44 |
Bilirubin >3 mg/dL | 2 | 4.44 |
Seizure | 0 | 0 |
Encephalopathy syndrome | 0 | 0 |
Albumin <2 g/dL | 0 | 0 |
Life threat/intervention needed | 0 | 0 |